NO934832L - Farmasöytisk sammensetning for forhindring eller behandling av arterioscherose - Google Patents

Farmasöytisk sammensetning for forhindring eller behandling av arterioscherose

Info

Publication number
NO934832L
NO934832L NO934832A NO934832A NO934832L NO 934832 L NO934832 L NO 934832L NO 934832 A NO934832 A NO 934832A NO 934832 A NO934832 A NO 934832A NO 934832 L NO934832 L NO 934832L
Authority
NO
Norway
Prior art keywords
pharmaceutical composition
arterioscherosis
prevention
treatment
prevent
Prior art date
Application number
NO934832A
Other languages
English (en)
Other versions
NO934832D0 (no
Inventor
Yusuke Satoh
Toshifumi Inami
Original Assignee
Hoechst Japan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Japan filed Critical Hoechst Japan
Publication of NO934832D0 publication Critical patent/NO934832D0/no
Publication of NO934832L publication Critical patent/NO934832L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Farmasøytisk sammensetning inneholdende glimepirid som aktiv ingrediens. Sammensetningen blir benyttet for å forhindre eller behandle arteriosclerosis uten noen påvirkning av lipldmetabolisme og uten økning av plasmainsulin-nivå.
NO934832A 1992-12-28 1993-12-27 Farmasöytisk sammensetning for forhindring eller behandling av arterioscherose NO934832L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP34747692A JP3465247B2 (ja) 1992-12-28 1992-12-28 動脈硬化症の予防および治療剤

Publications (2)

Publication Number Publication Date
NO934832D0 NO934832D0 (no) 1993-12-27
NO934832L true NO934832L (no) 1994-06-29

Family

ID=18390484

Family Applications (1)

Application Number Title Priority Date Filing Date
NO934832A NO934832L (no) 1992-12-28 1993-12-27 Farmasöytisk sammensetning for forhindring eller behandling av arterioscherose

Country Status (12)

Country Link
US (1) US5416105A (no)
EP (1) EP0604853A3 (no)
JP (1) JP3465247B2 (no)
KR (1) KR940013503A (no)
CN (1) CN1104888A (no)
AU (1) AU666992B2 (no)
CA (1) CA2112195A1 (no)
HU (1) HUT69398A (no)
IL (1) IL108197A0 (no)
NO (1) NO934832L (no)
PL (1) PL301653A1 (no)
ZA (1) ZA939707B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5631275A (en) * 1993-12-30 1997-05-20 Hoechst Aktiengesellschaft Substituted benzenesulfonylureas and -thioureas, preparation processes and possible uses of pharmaceutical preparations based on these compounds
JP3195363B2 (ja) * 1995-06-30 2001-08-06 ザイモジェネティクス，インコーポレイティド Ｐｄｇｆアンタゴニストとしての４−〔２−（ｎ−２−カルボキサミドインドール）アミノエチル〕ベンゼンスルホンアミドまたはスルホニル尿素
KR100413745B1 (ko) * 1995-08-30 2004-03-20 정규범 컨버터스위치의스위칭손실및노이즈저감회로
ES2284829T3 (es) * 2002-01-25 2007-11-16 Laboratorios Silanes, S.A. De C.V. Composicion farmaceutica que se usa para controlar la glucosa en sangre en pacientes con diabetes de tipo 2.
KR20110119813A (ko) 2003-09-17 2011-11-02 보드 오브 리전츠 더 유니버시티 오브 텍사스 시스템 메카니즘-기초 표적화된 췌장 베타 세포 영상화 및 치료법
KR100698595B1 (ko) * 2003-09-29 2007-03-21 보령제약 주식회사 무정형 또는 준결정형 글리메피리드, 이의 제조방법 및 무정형 또는 준결정형 글리메피리드를 포함하는 약학적조성물
DE102005034484A1 (de) * 2005-07-20 2007-02-01 Alfred E. Tiefenbacher Gmbh & Co.Kg Verfahren zur Herstellung von Glimepirid enthaltenden pharmazeutischen Zusammensetzungen
MXPA05009633A (es) * 2005-09-08 2007-03-07 Silanes Sa De Cv Lab Composicion farmaceutica estable de glimepirida de liberacion inmediata y metformina de liberacion prolongada.
TR201101809A1 (tr) 2010-12-21 2012-07-23 Sanovel İlaç Sanayi̇ Ve Ti̇caret Anoni̇m Şi̇rketi̇ Vildagliptin ve glimepirid kombinasyonları.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2951135A1 (de) * 1979-12-19 1981-06-25 Hoechst Ag, 6230 Frankfurt Sulfonylharnstoffe, verfahren zu ihrer herstellung, pharmazeutische praeparate auf basis dieser verbindungen und ihre verwendung
US4411903A (en) * 1980-08-11 1983-10-25 American Cyanamid Company 4-[(Monosubstituted-alkyl)amino]benzoic acids and analogs as hypolipidemic and antiatherosclerotic agents
CA1339784C (en) * 1988-06-23 1998-03-31 Shinya Inoue Pyrrolecarboxylic acid derivatives

Also Published As

Publication number Publication date
ZA939707B (en) 1994-08-29
JPH06192088A (ja) 1994-07-12
HUT69398A (en) 1995-09-28
HU9303758D0 (en) 1994-04-28
NO934832D0 (no) 1993-12-27
IL108197A0 (en) 1994-04-12
KR940013503A (ko) 1994-07-15
PL301653A1 (en) 1994-07-11
CA2112195A1 (en) 1994-06-29
US5416105A (en) 1995-05-16
EP0604853A2 (en) 1994-07-06
EP0604853A3 (en) 1994-08-24
JP3465247B2 (ja) 2003-11-10
AU666992B2 (en) 1996-02-29
CN1104888A (zh) 1995-07-12
AU5270693A (en) 1994-07-07

Similar Documents

Publication Publication Date Title
ATE207342T1 (de) Gegen hautalterung wirksame stoffe oder wirkstoffkombinationen und zubereitungen
NO931267D0 (no) Fremgangsmaate for behandling eller forebyggelse av type 1diabetes ved oral administrering av insulin
BG97678A (en) Beta -carotene and/or vitamin e therapy for inhibition of major vascular events
BR9801008A (pt) Formulação aerossol adequada para terapia, profilaxia ou contenção de infecções da mycobacterium tuberculosis de um pacientes sofrendo de tuberculose
RU94040855A (ru) Фармацевтическая композиция на основе эмульсии масло в воде для местного применения, содержащая ароматическое активное вещество
NO900251L (no) Fremgangsmaate for behandling eller hindring av intrinsik aldret hud med retinoider.
ATE201597T1 (de) Verabreichung von riluzol zur behandlung von neuro-aids
NO962405L (no) Transdermalt terapeutisk system for forhindring av forgiftning med fosfororganiske nervegifter som omfatter et parasympatikomimetikum og et parasympatikolytikum
AU564439B2 (en) Pharmaceutical compositions containing l-alpha- glycerylphosphorylcholine
FI951511A0 (fi) IL-10:n käyttö insuliinista riippuvan diabetes mellituksen ennaltaestoon tai hoitoon
WO1987000432A3 (en) Use of melatonin or related compounds for the treatment of psoriasis
AP9801286A0 (en) Therapeutic compounds.
LV10839A (lv) Arstniecibas lidzeklis lipidu un holesterina vielmainas traucejumu profilaksei un arstesanai so traucejumu profilakses un arstesanas panemiens
NO941915L (no) Madikament for nervebeskyttelse
BR9702284A (pt) Método cosmético para tratamento e prevenção dos sinais de envelhecimento da pele
NO934832D0 (no) Farmasoeytisk sammensetning for forhindring eller behandling av ar terioscherose
FI940637A0 (fi) Karbakolia ja muita kolinergisiä substansseja sisältävä farmaseuttinenkoostumus
ATE141510T1 (de) Arzneimittel enthaltend cd14
DK0722325T3 (da) Præparat til behandling eller forebyggelse af herpes
NO962503L (no) Anvendelse av penoksyfyllin ved behandling av multippel sklerose
NO953003L (no) Anvendelse av ifenprodil og diastereoisomerer derav for fremstilling av medisinske preparater
NO990283L (no) Formulering for behandling og/eller profylakse av demens
WO1997026880A3 (en) Use of a combination of delavirdine and one or more protease inhibitors in hiv-1 infected patients
MX9302986A (es) Medicamento que contiene metrifonato y procedimiento para su preparacion
NO961046L (no) Fremgangsmåte for behandling av pasienter med akutt hjerteinfarkt som ikke gjennomgår trombolytisk behandling med hirudin og acetylsalicylsyre